Products

Human XPF(Xeroderma Pigmentosum, Complementation Group F) ELISA Kit
ELK5033
Size： Price：
48 T $320.00
96 T $458.00
Download ① Send email to us

Overview

Product name: Human XPF(Xeroderma Pigmentosum, Complementation Group F) ELISA Kit
Reactivity: Human
Alternative Names: ERCC4; RAD1; Excision Repair Cross-Complementing Rodent Repair Deficiency,Complementation 4; DNA repair protein complementing XP-F cells; DNA excision repair ERCC-4
Assay Type: Sandwich
Sensitivity: 0.061 ng/mL
Standard: 10 ng/mL
Detection Range: 0.16-10 ng/mL
Sample Type: Tissue homogenates, cell lysates and other biological fluids.
Assay Length: 3.5h
Research Area: Developmental science;
Uniprot ID: Q92889
Test principle: The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Human XPF. Standards or samples are added to the appropriate microtiter plate wells then with a biotin-conjugated antibody specific to Human XPF. Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added, only those wells that contain Human XPF, biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Human XPF in the samples is then determined by comparing the OD of the samples to the standard curve.

Standard curve

Concentration (ng/mL) OD Corrected OD
10.00 2.154 2.051
5.00 1.647 1.544
2.50 1.412 1.309
1.25 0.813 0.710
0.63 0.532 0.429
0.32 0.335 0.232
0.16 0.221 0.118
0.00 0.103 0.000

Precision

Intra-assay Precision (Precision within an assay)：CV%<8%

Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.

Inter-assay Precision (Precision between assays)：CV%<10%

Three samples of known concentration were tested in forty separate assays to assess inter-assay precision.

Recovery

Matrices listed below were spiked with certain level of recombinant XPF and the recovery rates were calculated by comparing the measured value to the expected amount of XPF in samples.
Matrix Recovery range Average
serum(n=5) 97-105% 101%
EDTA plasma(n=5) 87-99% 92%
Heparin plasma(n=5) 88-107% 94%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of XPF and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
Matrix 1:2 1:4 1:8 1:16
serum(n=5) 85-92% 79-96% 89-101% 85-97%
EDTA plasma(n=5) 86-94% 93-102% 89-97% 85-94%
Heparin plasma(n=5) 87-102% 82-91% 86-93% 81-94%